AirSculpt TechnologiesAIRS -1.20%73 PB Ratio is 3.20 as of Jun. 25, 2026, which is 20% below its 10-year median of 4.00. GuruFocus rates AIRS with a GF Score™ of 73/100 and a GF Value™ of $3.93 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 611 Healthcare Providers & Services companies, AirSculpt Technologies ranks worse than 71.19% on this metric.
The historical rank and industry rank for AirSculpt Technologies's PB Ratio or its related term are showing as below:
AIRS'
s PB Ratio Range Over the Past 10 Years
Min: 1.16 Med: 4 Max: 11.45
Current: 3.2
During the past 7 years, AirSculpt Technologies's highest PB Ratio was 11.45. The lowest was 1.16. And the median was 4.00.
AIRS's PB Ratio is ranked worse than 71.19% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.96
vs AIRS: 3.20
During the past 12 months, AirSculpt Technologies's average Book Value Per Share Growth Rate was 7.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -7.40% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of AirSculpt Technologies was 2.60% per year. The lowest was -16.60% per year. And the median was -8.40% per year.
Back to Basics: PB Ratio
AirSculpt Technologies (NAS:AIRS) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, AirSculpt Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AirSculpt Technologies PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AirSculpt Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where AirSculpt Technologies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
AirSculpt Technologies (AIRS) has a PB Ratio of 3.20 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on AirSculpt Technologies and its competitors. This is 20% below median its historical median of 4.00. Over the past decade, AirSculpt Technologies' PB Ratio has ranged from 1.16 to 11.45. According to the industry distribution chart, AirSculpt Technologies ranks #435 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 71.2%.
Is AirSculpt Technologies' PB Ratio too high?
AirSculpt Technologies' current PB Ratio of 3.20 is 20% below median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.16 to a high of 11.45. The Healthcare Providers & Services industry median PB Ratio is 1.96. AirSculpt Technologies' value of 3.20 is 63.3% above this industry median. Based on the distribution chart, AirSculpt Technologies ranks #435 out of 611 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, AirSculpt Technologies has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AirSculpt Technologies' PB Ratio compare to CYH and CCRN?
According to the Healthcare Providers & Services industry distribution chart, AirSculpt Technologies ranks #435 out of 611 companies for PB Ratio. This places AirSculpt Technologies in the lower half of its industry. The industry median PB Ratio is 1.96. AirSculpt Technologies' value of 3.20 is 63.3% above this benchmark. Historically, AirSculpt Technologies' own PB Ratio has ranged from 1.16 to 11.45 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 1.96, AirSculpt Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.96, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AirSculpt Technologies's current PB Ratio of 3.20 is 63.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on AirSculpt Technologies and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AirSculpt Technologies's current PB Ratio is 3.20, which is 20% below median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AirSculpt Technologies stock overvalued right now?
Based on GuruFocus' analysis, AirSculpt Technologies (AIRS) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.93, compared to a current price of $4.55 — trading 15.8% above its estimated fair value. The current PB Ratio is 3.20, which is 20% below median its 10-year median of 4.00 and 63.3% above the Healthcare Providers & Services industry median of 1.96. AirSculpt Technologies' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For AirSculpt Technologies (AIRS), the current PB Ratio is 3.20 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AirSculpt Technologies (AIRS) Overvalued in 2026?
Based on GuruFocus' analysis, AirSculpt Technologies stock appears to be overvalued.
The current stock price of $4.55 is trading 15.8% above its estimated GF Value™ of $3.93.
GuruFocus considers AirSculpt Technologies to be Modestly Overvalued.
Key valuation signals for AIRS:
PB Ratio: 3.20 (20% below median its 10-year median of 4.00)
GF Value™: $3.93 vs. price of $4.55 (15.8% above fair value)
Industry Position: 63.3% above the Healthcare Providers & Services median (#435 of 611)
No single metric tells the full story. See the AIRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
73GF Score
Get the complete analysis for AIRS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRS has been successfully added to your 
